Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted drug for patients with a specific genetic mutation.
from Reuters: Health News https://ift.tt/2NZEpGh
No comments:
Post a Comment